a public good project by the
Synthesis
Company
of California

© 2026

Seiji Mogi | doi.page

0 works0 citations0 h-index

Google Scholar OpenAlex

Seiji Mogi

Showa General Hospital(JP)

Research Areas

Rheumatoid Arthritis Research and Therapies, Autoimmune and Inflammatory Disorders Research, Biosimilars and Bioanalytical Methods

Most-Cited Works

→ Mechanism‐based approach using a biomarker response to evaluate tocilizumab subcutaneous injection in patients with rheumatoid arthritis with an inadequate response to synthetic DMARDs (MATSURI study)(2013)30 cited